valerophenone has been researched along with benzimidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bánhegyi, P; Erös, D; Hafenbradl, D; Hegymegi-Barakonyi, B; Hollósy, F; Kéri, G; Klebl, B; Mészáros, G; Obert, S; Orfi, L; Pató, J; Székelyhidi, Z; Wáczek, F | 1 |
| Borges, F; Chavarria, D; Fernandes, C; Gil-Martins, E; Oliveira, PJ; Remião, F; Silva, C; Silva, R; Silva, T; Silva, V; Soares, P | 1 |
2 other study(ies) available for valerophenone and benzimidazole
| Article | Year |
|---|---|
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
Topics: Antiviral Agents; Enzyme Inhibitors; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Protein Serine-Threonine Kinases; Quinoxalines; Structure-Activity Relationship | 2005 |
Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.
Topics: Alkaloids; Benzodioxoles; Caco-2 Cells; Cell Differentiation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |